9-(2-hydroxy-3-nonyl)adenine has been researched along with Leukemia, Basophilic, Acute in 1 studies
9-(2-hydroxy-3-nonyl)adenine: specific inhibitor of adenosine deaminase
Leukemia, Basophilic, Acute: A rare acute myeloid leukemia in which the primary differentiation is to BASOPHILS. It is characterized by an extreme increase of immature basophilic granulated cells in the bone marrow and blood. Mature basophils are usually sparse.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lloyd, HG | 1 |
| Ross, L | 1 |
| Li, KM | 1 |
| Ludowyke, RI | 1 |
1 other study available for 9-(2-hydroxy-3-nonyl)adenine and Leukemia, Basophilic, Acute
| Article | Year |
|---|---|
Evidence that IgE receptor stimulation increases adenosine release from rat basophilic leukaemia (RBL-2H3) cells.
Topics: Adenine; Adenosine; Animals; beta-N-Acetylhexosaminidases; Cytoplasmic Granules; Leukemia, Basophili | 1998 |